Applications and safety of gold nanoparticles as therapeutic devices in clinical trials
10.1016/j.jpha.2023.06.001
- Author:
Leeann YAO
1
;
Dejan BOJIC
;
Mingyao LIU
Author Information
1. Latner Thoracic Surgical Research Laboratories,Toronto General Hospital Research Institute,University Health Network,Toronto,ON,M5G 1L7,Canada
- Keywords:
Nanomedicine;
Clinical studies;
Gold nanoparticles;
Safety;
Applications
- From:
Journal of Pharmaceutical Analysis
2023;13(9):960-967
- CountryChina
- Language:Chinese
-
Abstract:
Use of gold nanoparticles(GNPs)in medicine is an emerging field of translational research with vast clinical implications and exciting therapeutic potential.However,the safety of using GNPs in human subjects is an important question that remains unanswered.This study reviews over 20 clinical trials focused on GNP safety and aims to summarize all the clinical studies,completed and ongoing,to identify whether GNPs are safe to use in humans as a therapeutic platform.In these studies,GNPs were implemented as drug delivery devices,for photothermal therapy,and utilized for their intrinsic thera-peutic effects by various routes of delivery.These studies revealed no major safety concerns with the use of GNPs;however,the number of trials and total patient number remains limited.Multi-dose,multi-center blinded trials are required to deepen our understanding of the use of GNPs in clinical settings to facilitate translation of this novel,multifaceted therapeutic device.Expanding clinical trials will require collaboration between clinicians,scientists,and biotechnology companies.
